174 related articles for article (PubMed ID: 35465681)
1. Comparing Post-Operative Outcomes of Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: Neoadjuvant Therapy Versus Surgery First Approach.
Hyman DW; Almerey T; Mujkanovic A; Hammons I; Tice M; Stauffer JA
Am Surg; 2022 Aug; 88(8):1868-1874. PubMed ID: 35465681
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Propensity-Matched Analysis of Postoperative Complications Using ACS-NSQIP.
Krell RW; McNeil LR; Yanala UR; Are C; Reames BN
Ann Surg Oncol; 2021 Jul; 28(7):3810-3822. PubMed ID: 33386542
[TBL] [Abstract][Full Text] [Related]
3. Impact of neoadjuvant therapy on postoperative outcomes after pancreaticoduodenectomy.
Cools KS; Sanoff HK; Kim HJ; Yeh JJ; Stitzenberg KB
J Surg Oncol; 2018 Sep; 118(3):455-462. PubMed ID: 30114330
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoperative Complications.
Marchegiani G; Andrianello S; Nessi C; Sandini M; Maggino L; Malleo G; Paiella S; Polati E; Bassi C; Salvia R
Ann Surg Oncol; 2018 Mar; 25(3):626-637. PubMed ID: 29214453
[TBL] [Abstract][Full Text] [Related]
5. Laparoscopic versus open pancreatic resection for ductal adenocarcinoma: separate propensity score matching analyses of distal pancreatectomy and pancreaticoduodenectomy.
Chen K; Pan Y; Huang CJ; Chen QL; Zhang RC; Zhang MZ; Wang GY; Wang XF; Mou YP; Yan JF
BMC Cancer; 2021 Apr; 21(1):382. PubMed ID: 33836678
[TBL] [Abstract][Full Text] [Related]
6. Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or Tail on Surgical and Oncological Outcome: A Propensity-Score Matched Multicenter Study.
Lof S; Korrel M; van Hilst J; Alseidi A; Balzano G; Boggi U; Butturini G; Casadei R; Dokmak S; Edwin B; Falconi M; Keck T; Malleo G; de Pastena M; Tomazic A; Wilmink H; Zerbi A; Besselink MG; Abu Hilal M;
Ann Surg Oncol; 2020 Jun; 27(6):1986-1996. PubMed ID: 31848815
[TBL] [Abstract][Full Text] [Related]
7. Incidence of Postoperative Complications Following Pancreatectomy for Pancreatic Cystic Lesions or Pancreatic Cancer.
Donovan EC; Prakash LR; Chiang YJ; Bruno ML; Maxwell JE; Ikoma N; Tzeng CD; Katz MHG; Lee JE; Kim MP
J Gastrointest Surg; 2023 Feb; 27(2):319-327. PubMed ID: 36443557
[TBL] [Abstract][Full Text] [Related]
8. Optimal Management of Resectable Pancreatic Head Cancer in the Elderly Patient: Does Neoadjuvant Therapy Offer a Survival Benefit?
Rieser CJ; Zenati M; Narayanan S; Bahary N; Lee KK; Paniccia A; Bartlett DL; Zureikat AH
Ann Surg Oncol; 2021 Oct; 28(11):6264-6272. PubMed ID: 33748894
[TBL] [Abstract][Full Text] [Related]
9. Impact of Neoadjuvant Therapy for Pancreatic Cancer: Transatlantic Trend and Postoperative Outcomes Analysis.
Davis CH; Augustinus S; de Graaf N; Wellner UF; Johansen K; Andersson B; Beane JD; Björnsson B; Busch OR; Gleeson EM; van Santvoort HC; Tingstedt B; Williamsson C; Keck T; Besselink MG; Koerkamp BG; Pitt HA;
J Am Coll Surg; 2024 Apr; 238(4):613-621. PubMed ID: 38224148
[TBL] [Abstract][Full Text] [Related]
10. Upfront Surgery and Surgery Following Neoadjuvant Treatment of Pancreatic Ductal Adenocarcinoma: A Comparative Analysis of Short-term Postoperative Outcomes.
Jung JH; Yoon SK; Yoon SJ; Shin SH; Han IW; Heo JS
Anticancer Res; 2021 Nov; 41(11):5703-5712. PubMed ID: 34732443
[TBL] [Abstract][Full Text] [Related]
11. Laparoscopic versus open pancreaticoduodenectomy for pancreatic adenocarcinoma: long-term results at a single institution.
Stauffer JA; Coppola A; Villacreses D; Mody K; Johnson E; Li Z; Asbun HJ
Surg Endosc; 2017 May; 31(5):2233-2241. PubMed ID: 27604369
[TBL] [Abstract][Full Text] [Related]
12. Does pre-operative chemoradiation for initially unresectable or borderline resectable pancreatic adenocarcinoma increase post-operative morbidity? A case-matched analysis.
Araujo RL; Gaujoux S; Huguet F; Gonen M; D'Angelica MI; DeMatteo RP; Fong Y; Kingham TP; Jarnagin WR; Goodman KA; Allen PJ
HPB (Oxford); 2013 Aug; 15(8):574-80. PubMed ID: 23458208
[TBL] [Abstract][Full Text] [Related]
13. Survival benefit of neoadjuvant therapy in patients with non-metastatic pancreatic ductal adenocarcinoma: A propensity matching and intention-to-treat analysis.
Sugimoto M; Takahashi N; Farnell MB; Smyrk TC; Truty MJ; Nagorney DM; Smoot RL; Chari ST; Carter RE; Kendrick ML
J Surg Oncol; 2019 Nov; 120(6):976-984. PubMed ID: 31452208
[TBL] [Abstract][Full Text] [Related]
14. Nationwide trends and outcomes of neoadjuvant chemotherapy in pancreatic cancer - an analysis of the Swedish national pancreatic cancer registry.
Sternby H; Andersson B
Scand J Gastroenterol; 2022 Nov; 57(11):1361-1366. PubMed ID: 35635264
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant Therapy for Pancreatic Cancer: Increased Use and Improved Optimal Outcomes.
Davis CH; Beane JD; Gazivoda VP; Grandhi MS; Greenbaum AA; Kennedy TJ; Langan RC; August DA; Alexander HR; Pitt HA
J Am Coll Surg; 2022 Apr; 234(4):436-443. PubMed ID: 35290262
[TBL] [Abstract][Full Text] [Related]
16. Thirty-day complication rates do not differ by race among patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma.
Mitsakos AT; Dennis SO; Parikh AA; Snyder RA
J Surg Oncol; 2021 Mar; 123(4):970-977. PubMed ID: 33497474
[TBL] [Abstract][Full Text] [Related]
17. Association Between Pancreatic Fistula and Long-term Survival in the Era of Neoadjuvant Chemotherapy.
Hank T; Sandini M; Ferrone CR; Rodrigues C; Weniger M; Qadan M; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
JAMA Surg; 2019 Oct; 154(10):943-951. PubMed ID: 31411659
[TBL] [Abstract][Full Text] [Related]
18. Impact of neoadjuvant therapy on post-operative pancreatic fistula: a systematic review and meta-analysis.
Kamarajah SK; Bundred JR; Boyle C; Oo J; Pandanaboyana S; Loveday B
ANZ J Surg; 2020 Nov; 90(11):2201-2210. PubMed ID: 32418344
[TBL] [Abstract][Full Text] [Related]
19. Surgical approach to pancreaticoduodenectomy for pancreatic adenocarcinoma: uncomplicated ends justify the means.
Naffouje SA; Pointer DT; Satyadi MA; Hodul P; Anaya DA; Pimiento J; Malafa M; Kim DW; Fleming JB; Denbo JW
Surg Endosc; 2022 Jul; 36(7):4912-4922. PubMed ID: 34859301
[TBL] [Abstract][Full Text] [Related]
20. Impact of diabetes mellitus on perioperative outcomes after resection for pancreatic adenocarcinoma.
Chu CK; Mazo AE; Sarmiento JM; Staley CA; Adsay NV; Umpierrez GE; Kooby DA
J Am Coll Surg; 2010 Apr; 210(4):463-73. PubMed ID: 20347739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
